Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Cardiology Pharmacist’s Insights on Stroke Prevention in NVAF With Evidence-Based DOAC Therapy

In this podcast, expert cardiology pharmacist Dr Stephanie Dwyer Kaluzna discusses evidence-based recommendations on the use of DOAC therapy in NVAF for stroke prevention.
Stephanie Dwyer Kaluzna, PharmD, BCCP
Released: April 25, 2022

This podcast is the second in a series of three featuring insights from expert cardiology pharmacists on nonvalvular atrial fibrillation (NVAF). In this episode, cardiology pharmacist Stephanie Dwyer Kaluzna, PharmD, BCCP, reviews key literature and guideline recommendations for stroke prevention in patients with NVAF. Dr Dwyer Kaluzna discusses the most recent evidence for prescribing, dosing, and monitoring direct oral anticoagulants (DOACs); using the risk-screening tools HAS-BLED and CHA2DS2-VASc to design patient-specific pharmacotherapy plans; and the use of DOACs in special patient populations, including older patients, patients with end-stage renal disease, and patients with low or high body weights.

Information on this Educational Activity

Faculty

Stephanie Dwyer Kaluzna, PharmD, BCCP

Clinical Assistant Professor
Department of Pharmacy Practice
University of Illinois Chicago College of Pharmacy
Cardiovascular Clinical Pharmacist
University of Illinois Hospital and Health Sciences System
Chicago, Illinois

Stephanie Dwyer Kaluzna, PharmD, BCCP, has no relevant conflicts of interest to report.

Program Medium

This program has been made available online.

Acknowledgements

Provided by ProCE, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Bristol-Myers Squibb
Pfizer Alliance

Related Content

Dr. Katherine Di Palo discusses use of novel potassium binders for the management of hyperkalemia, from ProCE

Katherine Di Palo, PharmD Released: May 13, 2022

Expert faculty provide practical strategies for successful management of hyperkalemia from ProCE

Katherine Di Palo, PharmD Michelle Richardson, PharmD, BCPS Pharmacists: 1.5 contact hours (0.15 CEUs) Released: May 12, 2022 Expired: May 11, 2023

Podcast featuring expert pharmacist insights on engaging patients and the healthcare team in collaborative, shared decision-making in NVAF management, from ProCE

Kathleen A. Lusk, PharmD, BCPS, BCCP Released: April 26, 2022

Podcast featuring pharmacists’ insights on the burden of and screening methods for undiagnosed NVAF, from ProCE

Stephanie Dwyer Kaluzna, PharmD, BCCP Kathleen A. Lusk, PharmD, BCPS, BCCP Released: April 25, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings